Xeris Biopharma Holdings
XERS
XERS
103 hedge funds and large institutions have $147M invested in Xeris Biopharma Holdings in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.7% more ownership
Funds ownership: 36.03% → 40.73% (+4.7%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 28
Holders
103
Holding in Top 10
2
Calls
$2.49M
Puts
$247K
Top Buyers
| 1 | +$10.4M | |
| 2 | +$5.38M | |
| 3 | +$4.74M | |
| 4 |
BlackRock
New York
|
+$2.41M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$1.99M |
Top Sellers
| 1 | -$8.23M | |
| 2 | -$1.22M | |
| 3 | -$1.04M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$741K |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$695K |